Artiva Biotherapeutics (ARTV) Receivables (2023 - 2026)
Artiva Biotherapeutics' (ARTV) quarterly Receivables came in at -$67000.0 in Q1 2026, down 128.63% year-on-year from $234000.0 in Q1 2025, and down 458.33% on a QoQ basis from -$12000.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Receivables (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Receivables data on file, last reported at -$67000.0 in Q1 2026.
- On a quarterly basis, Receivables fell 128.63% year-over-year to -$67000.0 in Q1 2026; TTM through Mar 2026 was -$67000.0, a 128.63% decrease from a year earlier, with the FY2025 full-year figure at -$79000.0, up 86.33% from the prior year.
- Receivables for Q1 2026 stood at -$67000.0, down from -$12000.0 in the prior quarter.
- Over the last five years, Receivables for ARTV reached as high as $1.8 million in Q4 2023 and fell as low as -$67000.0 in Q1 2026.
- Historically, Receivables has averaged $466444.4 across 4 years, with a median of $79000.0 in 2025.
- On a YoY basis, Receivables climbed as much as 88.73% in 2025 and fell as far as 185.71% in 2025.
- Year by year, Receivables stood at $1.8 million in 2023, then plunged by 99.2% to $14000.0 in 2024, then plunged by 185.71% to -$12000.0 in 2025, then plunged by 458.33% to -$67000.0 in 2026.
- Per Business Quant data, the three most recent Receivables figures were -$67000.0 in Q1 2026, -$12000.0 in Q4 2025, and $79000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Artiva Biotherapeutics | 249.99 Mn | 249.99 Mn | - | -67,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 234,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 701,000.00 |
| Jun 30, 2024 | 1.46 Mn |
| Dec 31, 2023 | 1.76 Mn |